Parenteral Hydration in Advanced Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

January 9, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Advanced CancerDehydration
Interventions
DRUG

Saline

1,000 ml of normal saline (0.9% sodium chloride) parenterally over 4 hours daily.

DRUG

Saline

100 ml of normal saline (0.9% sodium chloride) parenterally over 4 hours daily.

Trial Locations (5)

77030

Houston Hospice and Palliative Care System, Houston

University of Texas MD Anderson Cancer Center, Houston

77054

Odyssey Healthcare of Houston, Houston

77081

Vitas Healthcare, Houston

77304

Odyssey Healthcare of Conroe, Conroe

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00423722 - Parenteral Hydration in Advanced Cancer Patients | Biotech Hunter | Biotech Hunter